LONDON & MILAN--(BUSINESS WIRE)--Ares Management Corporation (“Ares”) (NYSE: ARES), a leading global alternative investment manager, announced today that Ares Alternative…
Winner of the “Biotherapies and Bioproduction” call for projects under the France 2030 plan, EVerZom receives €3 million in government…
Press release Maxim Group initiates the coverage of the CROSSJECT share with a BUY recommendation and a target price of…